Eliminates use of vaccines containing mercury over three years.
Summary
Assembly Bill 4868 would phase out the administration of vaccines containing mercury in New Jersey over a three-year period. The bill sets a step-down schedule: starting January 1, 2016, health care providers could not administer certain influenza vaccines above specified mercury thresholds, or other vaccines containing more than a trace amount of mercury; beginning January 1, 2017, vaccines containing more than a trace amount of mercury would be prohibited; and beginning January 1, 2018, vaccines containing any amount of mercury would be prohibited. The bill defines “trace amount” as less than 0.0002% mercury.
The bill also creates a public health exception. The Commissioner of Health may authorize use of vaccines with higher mercury levels if necessary to prevent or respond to a disease outbreak and if insufficient vaccine supply exists to protect the public. In addition, patients receiving a vaccine containing more than a trace amount of mercury must be informed in advance that the vaccine contains mercury. The Commissioner of Health is directed to adopt implementing rules and regulations, and the act would take effect immediately.
Impact
This bill would amend and supplement Title 26 of the Revised Statutes by imposing state-level restrictions on which vaccines health care providers may administer based on mercury content. It would directly affect physicians, clinics, pharmacies, public health programs, vaccine suppliers, and patients receiving immunizations in New Jersey, especially influenza vaccination programs and any vaccine formulations using thimerosal or other mercury-containing preservatives. The bill would also require the Department of Health to establish regulations and would give the commissioner limited emergency authority to waive the restriction during outbreaks or shortages.
Sentiment
No committee transcripts or recorded votes are provided, so there is no documented legislative debate or vote history to gauge support or opposition. Based on the bill text and sponsor statement, the measure is framed as a public health precaution intended to reduce mercury exposure, particularly for children, and to encourage use of mercury-free vaccines. The overall tone of the bill is precautionary and consumer-protective.
Contention
The main point of contention is likely to be the balance between reducing mercury exposure and preserving flexibility in vaccine supply and outbreak response. Supporters would emphasize eliminating thimerosal and advancing safer vaccine formulations, while opponents or skeptics may question the need for a state ban given existing federal guidance, the limited presence of thimerosal in most vaccines, and the potential for supply constraints. The bill’s emergency exception suggests an acknowledgment that some mercury-containing vaccines may still be needed in limited circumstances.